跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,899 条关于
“HRS-AKI”
全部
6,899
临床试验
3,432
药物
1,006
机构
56
资讯
2,405
去年
Mallinckrodt to Present Five Clinical Studies on TERLIVAZ for Hepatorenal Syndrome at DDW 2025
10个月前
Mallinckrodt to Present New Terlipressin Data at Kidney Week 2025 for Hepatorenal Syndrome Treatment
去年
Tailored EHR Alerts Fail to Improve AKI Management in Hospitalized Patients: KAT-AKI Trial
11个月前
HengRui Advances KRAS G12D Inhibitor HRS-4642 to Phase 3 Trial in Pancreatic Cancer
上个月
SeaStar Medical Reports 82% QUELIMMUNE Revenue Growth as NEUTRALIZE-AKI Trial Advances Toward Adult AKI Indication
去年
SeaStar Medical's SCD Receives FDA Breakthrough Designation for Chronic Dialysis
去年
Hengrui Licenses Heart Disease Drug HRS-1893 to Braveheart Bio for $65M Upfront, Potential $1B+ Total
去年
Merck Licenses Oral Lipoprotein(a) Inhibitor HRS-5346 from Hengrui Pharma in $1.97 Billion Deal
去年
Glucarpidase Improves Kidney Recovery in Methotrexate-Associated Acute Kidney Injury
去年
SeaStar Medical Advances AKI Trial with New Site Activations and Enrollment Milestones
第 1 页,共 241 页
上一页
下一页